Gestational diabetes mellitus: an opportunity of a lifetime
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Gestational diabetes mellitus is defined as carbohydrate intolerance of any degree that begins or is first recognized during pregnancy.1 It complicates approximately 4% of all pregnancies in the United States1 and 3-5% in the United Kingdom.2 Notably, variable prevalence rates between 1-14%1 have been reported due to factors including differences in the diagnostic criteria used to define both gestational diabetes and Type 2 diabetes mellitus,3-6 as well as the heterogeneous racial/ethnic populations studied.7 Despite controversy over diagnostic criteria, the risks associated with gestational diabetes in pregnancy have been well-recognized. These have included neonatal risks such as macrosomia, maternal risks such as increased Cesarean delivery rate,8 and their respective comorbidities. Additionally, the impact of gestational diabetes after the pregnancy has been appreciated. The incidence rate of Type 2 diabetes after a pregnancy complicated by gestational diabetes has ranged from 2.6% to over 70% in studies examining women from 6 weeks to 28 years postpartum.9 Difficulty in precisely defining the incidence of Type 2 diabetes in women with a history of gestational diabetes has been attributed to factors such as varied diagnostic criteria for both gestational diabetes and Type 2 diabetes,3-6 insulin use during pregnancy, longer periods of postpartum follow-up,9 as well as missed opportunities in identifying and diagnosing these women through education and screening efforts.10 In today’s Lancet, Leanne Bellamy and colleagues11 report findings from their meta-analysis of cohort studies examining the correlation between gestational diabetes and subsequent development of Type 2 diabetes. Their analysis included 20 studies representing 675,455 women and 10,859 cases of Type 2 diabetes. They observed a nearly 7.5 fold increased risk of developing Type 2 diabetes for women who had gestational diabetes during pregnancy. Moreover, when considering the duration of follow-up, women within 5 years of a pregnancy complicated by gestational diabetes had a relative risk of 4.69 which more than doubled to 9.34 among women who were examined more than 5 years postpartum. Because of differences in diagnostic criteria for both gestational diabetes and Type 2 diabetes across studies, as well as variable distributions of gestational diabetes risk factors among the studies, the authors conducted several subgroup analyses in order to discover potential sources of heterogeneity. They did not uncover heterogeneity resulting from duration of follow-up, ethnicity, maternal age, maternal BMI during pregnancy or postpartum, or diagnostic criteria for gestational diabetes and Type 2 diabetes. However, other potential sources of heterogeneity were not examined in subgroup analyses, possibly due to an inability to gather complete data in the setting of a meta-analysis. Parity is potentially a risk factor for both gestational diabetes12 and Type 2 diabetes13 and is often handled as an adjusted covariate in the setting of a multivariate analysis. Therefore, dichotomizing this parameter, if parity data could indeed be captured from the relevant studies, may provide insight into sources of heterogeneity. Additionally, lifestyle information, which cannot always be gleaned from study descriptions of patient characteristics, would also provide beneficial information when considering sources of heterogeneity. For example, lactation has been demonstrated to decrease the risk of developing Type 2 diabetes among women with a history of gestational diabetes.14 Nevertheless, I recognize that a meta-analysis is inherently limited by the data contained in the studies under examination and, given the significant multicollinearity among risk factors for gestational diabetes and Type 2 diabetes, teasing out specific attributable risk will prove challenging if not impossible. Sufficient evidence has been accumulated to support the assertion that gestational diabetes is a harbinger of Type 2 diabetes in women who are presumably predisposed to Type 2 diabetes and are faced with the metabolic challenges of pregnancy. The current task is to ensure that this information is disseminated to clinicians, and that they use this information to target women who have experienced gestational diabetes for Type 2 diabetes prevention efforts. Consequently, future studies should address how the progression from gestational diabetes to Type 2 diabetes can be arrested in order to develop evidence-based approaches to the health care of this population. Given the compelling data evidencing the link between gestational diabetes and the development of Type 2 diabetes, we as clinicians are afforded the rare opportunity to alter the natural course of disease and impact a woman’s future health today. Carpe diem!
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis
Bellamy, L., Casas, J.-P., Hingorani, A. D., & Williams, D. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60731-5 · Cited by 3,253
Gestational Diabetes and the Incidence of Type 2 Diabetes
Kim, C., Newton, K. M., & Knopp, R. H. (2002) · Diabetes Care · doi:10.2337/diacare.25.10.1862 · Cited by 2,276
Buchanan, T. A., & Xiang, A. H. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200524531 · Cited by 2,123
Criteria for screening tests for gestational diabetes
Carpenter, M. W., & Coustan, D. R. (1982) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(82)90349-0 · Cited by 1,924
Epidemiology of gestational diabetes mellitus and its association with Type 2 diabetes
Ben‐Haroush, A., Yogev, Y., & Hod, M. (2004) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.00985.x · Cited by 856
Lawrence, J. M., Contreras, R., Chen, W., & Sacks, D. A. (2008) · Diabetes Care · doi:10.2337/dc07-2345 · Cited by 658
Recurrence of Gestational Diabetes Mellitus
Kim, C., Berger, D. K., & Chamany, S. (2007) · Diabetes Care · doi:10.2337/dc06-2517 · Cited by 367
Cited by
Intimate partner violence during pregnancy: analysis of prevalence data from 19 countries
Devries, K. M., Kishor, S., Johnson, H., Stöckl, H., Bacchus, L. J., Garcia-Moreno, C., & Watts, C. (2010) · Reproductive Health Matters · doi:10.1016/s0968-8080(10)36533-5 · Cited by 505
Lu, Q., Zhang, X., Wang, Y., Li, J., Xu, Y., Song, X., Su, S., Zhu, X., Vitiello, M. V., Shi, J., et al. (2021) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2021.101436 · Cited by 311
Bao, W., Tobias, D. K., Bowers, K., Chavarro, J., Vaag, A., Grunnet, L. G., Strøm, M., Mills, J., Liu, A., Kiely, M., et al. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.1795 · Cited by 166
Bao, W., Yeung, E., Tobias, D. K., Hu, F. B., Vaag, A. A., Chavarro, J. E., Mills, J. L., Grunnet, L. G., Bowers, K., Ley, S. H., et al. (2015) · Diabetologia · doi:10.1007/s00125-015-3537-4 · Cited by 137
“Women with a history of GDM represent a ‘revealed’ high-risk group for type 2 diabetes [10], because GDM cases are routinely identified through blood glucose testing between 24 and 28 weeks of gestation [1].”
BackgroundZhou, X., Chen, R., Zhong, C., Wu, J., Li, X., Li, Q., Cui, W., Yi, N., Xiao, M., Yin, H., et al. (2018) · British Journal of Nutrition · doi:10.1017/s0007114518002453 · Cited by 62
Metadata
- Authors
- Bentley-Lewis, R.
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2009-05
- Volume
- 373
- Issue
- 9677
- Pages
- 1738-1740
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W1964333664
- Cited by
- 36
- References
- 7
- FWCI
- 3.15
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Gestational diabetes mellitus: an opportunity of a lifetime. https://app.cochat.ai/papers/10.1016/s0140-6736(09)60958-2
- The paper
- Bentley-Lewis, R. (2009). Gestational diabetes mellitus: an opportunity of a lifetime. The Lancet. https://doi.org/10.1016/s0140-6736(09)60958-2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.